The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Open accessAbstract
The discovery of genetic forms of Parkinson's disease (PD) has highlighted the importance of the autophagy/lysosomal and mitochondrial/oxidative stress pathways in disease pathogenesis. However, recently identified PD-linked genes, including DNAJC6 (auxilin), SYNJ1 (synaptojanin 1), and the PD risk gene SH3GL2 (endophilin A1), have also highlighted disruptions in synaptic vesicle endocytosis (SVE) as a significant contributor to disease pathogenesis. Additionally, the roles of other PD genes such as LRRK2, PRKN, and VPS35 in the regulation of SVE are beginning to emerge. Here we discuss the recent work on the contribution of dysfunctional SVE to midbrain dopaminergic neurons' selective vulnerability and highlight pathways that demonstrate the interplay of synaptic, mitochondrial, and lysosomal dysfunction in the pathogenesis of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Synaptic dysfunction contributes to disease pathogenesis in PD (Nguyen et al. 2019) and may be linked to cognitive and motor dysfunction (Bereczki et al. 2017; Moran et al. 2008).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Nguyen et al. 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Steger, M., Tonelli, F., Ito, G., Davies, P., Trost, M., Vetter, M., Wachter, S., Lorentzen, E., Duddy, G., Wilson, S., et al. (2016) · eLife · doi:10.7554/elife.12813 · Cited by 1,042
Mitochondria–lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis
Wong, Y. C., Ysselstein, D., & Krainc, D. (2018) · Nature · doi:10.1038/nature25486 · Cited by 911
Self-citationDopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., et al. (2017) · Science · doi:10.1126/science.aam9080 · Cited by 874
Self-citationActivity-driven local ATP synthesis is required for synaptic function
Rangaraju, V., Calloway, N., & Ryan, T. A. (2014) · Cell · doi:10.1016/j.cell.2013.12.042 · Cited by 836
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 726
Pacelli, C., Giguère, N., Bourque, M.-J., Lévesque, M., Slack, R. S., & Trudeau, L. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.050 · Cited by 530
Cited by
Sorted by citations
Items 101–200 of 323
Jęśko, H. M., Cieślik, M., Gromadzka, G., & Adamczyk, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104853 · Cited by 30
Alieva, A. K., Rudenok, M. M., Filatova, E. V., Karabanov, A. V., Doronina, O. B., Doronina, K. S., Kolacheva, A. A., Ugrumov, M. V., Illarioshkin, S. N., Slominsky, P. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57938-3 · Cited by 27
Bennett, J. P., & Onyango, I. G. (2021) · Biomedicines · doi:10.3390/biomedicines9020225 · Cited by 32
Crossroads between membrane trafficking machinery and copper homeostasis in the nerve system
Wen, M., Xie, X., Huang, P.-S., Yang, K., & Chen, T. (2021) · Open Biology · doi:10.1098/rsob.210128 · Cited by 29
Potential application of heat shock proteins as therapeutic targets in Parkinson's disease
Guo, H., Yi, J., Wang, F., Lei, T., & Du, H. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105453 · Cited by 26
Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis
Chu, C., Yu, L., Chen, W., Tian, F., & Zhai, Q. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.07.004 · Cited by 27
Ng, X. Y., Wu, Y., Lin, Y., Yaqoob, S. M., Greene, L. E., Camilli, P. V. D., & Cao, M. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00465-5 · Cited by 28
Respiratory Function and Dysfunction in Parkinson-Type Neurodegeneration
Pokusa, M., Hajdúchová, D., Budaj, T., & Trancikova, A. K. (2020) · Physiological Research · doi:10.33549/physiolres.934405 · Cited by 30
RNA sequestration driven by amyloid formation: the alpha synuclein case
Rupert, J., Monti, M. M., Zacco, E., & Tartaglia, G. G. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad857 · Cited by 28
Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy
Abela, L., Gianfrancesco, L., Tagliatti, E., Rossignoli, G., Barwick, K. E., Zourray, C., Reid, K. M., Budinger, D., Ng, J., Counsell, J. R., et al. (2024) · Brain · doi:10.1093/brain/awae020 · Cited by 25
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
He, Y., Fan, Y., Ahmadpoor, X., Wang, Y., Li, Z. A., Zhu, W., & Lin, H. (2024) · Medicinal Research Reviews · doi:10.1002/med.22047 · Cited by 29
Wen, G., Pang, H., Wu, X., Jiang, E., Zhang, X., & Zhan, X. (2021) · Aging · doi:10.18632/aging.203415 · Cited by 26
Zhao, Y., Pan, H.-X., Liu, Z., Wang, Y., Zeng, Q., Fang, Z., Luo, T., Xu, K., Wang, Z., Zhou, X. C., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749109 · Cited by 27
Brandes, M. S., Zweig, J. A., Tang, A. L., & Gray, N. E. (2021) · Antioxidants · doi:10.3390/antiox11010026 · Cited by 25
Dang, X., Zhang, Z., & Luo, X. (2022) · Movement Disorders · doi:10.1002/mds.29239 · Cited by 25
Su, Y., Mao, L., Wang, Q., Xu, X., Qin, P., Huang, H., Zhang, Y., Zhou, Y., & Yan, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1837278 · Cited by 26
Wu, J., Zou, W., Hu, M., Tian, Q., Xiao, F., Li, M., Zhang, P., Chen, Y., & Jiang, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13587 · Cited by 25
Xie, W., Jiao, B., Bai, Q., Ильин, В. Н., Sun, M., Burton, C. E., Kolodieznyi, D., Calderon, M. J., Stolz, D. B., Opresko, P. L., et al. (2020) · eLife · doi:10.7554/elife.51845 · Cited by 25
Gao, X., Huang, Z., Feng, C., Guan, C., Li, R., Xie, H., Chen, J., Li, M., Que, R., Deng, B., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa244 · Cited by 29
Neurodegeneration models in Parkinson’s disease: cellular and molecular paths to neuron death
Álvarez‐Luquín, D. D., González-Fernández, R. R., Torres-Velasco, M. E., Ichikawa-Escamilla, E., Arce-Sillas, A., Martínez‐Martínez, E., Miranda-Narváez, C. L., Rodríguez-Ramírez, J. F., & Adalid-Peralta, L. V. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00279-w · Cited by 29
Human genetic analyses of organelles highlight the nucleus in age-related trait heritability
Gupta, R., Karczewski, K. J., Howrigan, D. P., Neale, B. M., & Mootha, V. K. (2021) · eLife · doi:10.7554/elife.68610 · Cited by 22
C-reactive protein: the nexus between inflammation and protein misfolding diseases
Roy, A., Zeller, J., Nero, T. L., Klepetko, J., Eisenhardt, S. U., Parker, M. W., McFadyen, J. D., & Peter, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1612703 · Cited by 23
Dassati, S., Schweigreiter, R., Buechner, S., & Waldner, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108378 · Cited by 22
Turcotte, M.-A., Garant, J., Cossette-Roberge, H., & Perreault, J. (2020) · RNA Biology · doi:10.1080/15476286.2020.1847866 · Cited by 22
Huenchuguala, S., & Segura‐Aguilar, J. (2024) · Antioxidants · doi:10.3390/antiox13091125 · Cited by 23
Gao, G., Shi, Y., Deng, H., & Krainc, D. (2025) · Nature Communications · doi:10.1038/s41467-025-57142-9 · Cited by 21
Self-citationQiu, R., Sun, W., Su, Y., Sun, Z., Fan, K., Liang, Y., Lin, X., & Zhang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123088 · Cited by 23
Innate and adaptive immunity in neurodegenerative disease
Huang, Y., Zhang, G., Li, S., Feng, J., & Zhang, Z. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05533-4 · Cited by 22
Zou, L. B., Zhang, X., Xiong, M., Meng, L., Tian, Y., Pan, L., Yuan, X., Chen, G., Wang, Z., Bu, L., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105326 · Cited by 20
Endophilin A2 regulates B-cell endocytosis and is required for germinal center and humoral responses
Malinova, D., Wasim, L., Newman, R., Riaño, A. M., Engels, N., & Tolar, P. (2021) · EMBO Reports · doi:10.15252/embr.202051328 · Cited by 20
Dictyostelium discoideum: A Model System for Neurological Disorders
Storey, C., Williams, R. S. B., Fisher, P. R., & Annesley, S. J. (2022) · Cells · doi:10.3390/cells11030463 · Cited by 20
Shared Genetics and Comorbid Genes of Amyotrophic Lateral Sclerosis and Parkinson's Disease
Tian, Y., Ma, G., Li, H., Zeng, Y., Zhou, S., Wang, X., Shan, S., Xu, Y., Xiong, J., & Cheng, G. (2023) · Movement Disorders · doi:10.1002/mds.29572 · Cited by 20
Lázaro, D. F., & Lee, V. M. ‐. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.017 · Cited by 20
Mancini, A., Mazzocchetti, P., Sciaccaluga, M., Megaro, A., Bellingacci, L., Beccano-Kelly, D. A., Filippo, M. D., Tozzi, A., & Calabresi, P. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00158 · Cited by 19
Metabolic determinants of leukocyte pathogenicity in neurological diseases
Runtsch, M. C., Ferrara, G. B., & Angiari, S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15169 · Cited by 20
Lin, T.-K., Lin, K.-J., Lin, K.-L., Liou, C.-W., Chen, S.-D., Chuang, Y.-C., Wang, P.-W., Chuang, J.-H., & Wang, T.-J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607392 · Cited by 19
Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
Harraz, M. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219441 · Cited by 24
Halász, H., Tárnai, V., Matkó, J., Nyitrai, M., & Szabó‐Meleg, E. (2024) · Cells · doi:10.3390/cells13070607 · Cited by 19
Ageing-Related Changes to H3K4me3, H3K27ac, and H3K27me3 in Purified Mouse Neurons
Signal, B., Phipps, A. J., Giles, K. A., Huskins, S. N., Mercer, T. R., Robinson, M. D., Woodhouse, A., & Taberlay, P. C. (2024) · Cells · doi:10.3390/cells13161393 · Cited by 23
Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics
Miyazaki, M., Hiramoto, M., Takano, N., Kokuba, H., Takemura, J., Tokuhisa, M., Hino, H., Kazama, H., & Miyazawa, K. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5028 · Cited by 21
Zhao, Y., Zhang, K., Pan, H., Wang, Y., Zhou, X., Xiang, Y., Xu, Q., Sun, Q., Tan, J., Yan, X., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.889057 · Cited by 19
Narváez-Pérez, L. F., Paz‐Bermúdez, F. J., Ávalos‐Fuentes, J. A., Campos‐Romo, A., Florán, B., & Segovia, J. (2023) · Gene Therapy · doi:10.1038/s41434-023-00414-0 · Cited by 19
Hassanein, L., Mulvey, B., Blankenship, H. E., Tish, M., Korukonda, A., Liles, L. C., Sharpe, A. L., Paré, J., Villalba, R. M., Chen, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.530845 · Cited by 19
Rotenone-Induced Neurodegeneration Is Enabled by a p38-Parkin-ROS Signaling Feedback Loop
Chen, J., Li, M., Zhou, X., Xie, A., Cai, Z., Fu, C., Peng, Y., Zhang, H., & Liu, L. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04190 · Cited by 18
Albanese, F., Domenicale, C., Volta, M., & Morari, M. (2022) · Biochemical Society Transactions · doi:10.1042/bst20211288 · Cited by 18
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
Checler, F., & da Costa, C. A. (2022) · Biomolecules · doi:10.3390/biom12040559 · Cited by 19
Peng, M., Zou, R., Yao, S., Meng, X., Wu, W., Zeng, F., Chen, Z., Yuan, S., Zhao, F., & Liu, W. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122871 · Cited by 20
Nayak, N., & Mishra, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102066 · Cited by 19
Liu, M., Liu, C., Xiao, X., Han, S., Bi, M., Jiao, Q., Chen, X., Yan, C., Du, X., & Jiang, H. F. (2022) · Aging Cell · doi:10.1111/acel.13618 · Cited by 19
He, T., Han, C., Liu, C., Chen, J., Yang, H., Zheng, L. T., Waddington, J. L., & Zhen, X. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06097-6 · Cited by 17
Li, L., Ho, P. W., Liu, H., Pang, S. Y.-Y., Chang, E. E.-S., Choi, Z. Y.-K., Malki, Y., Kung, M. H.-W., Ramsden, D. B., & Ho, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073646 · Cited by 17
Connectivity impairment of cerebellar and sensorimotor connector hubs in Parkinson’s disease
Bagarinao, E., Kawabata, K., Watanabe, H., Hara, K., Ohdake, R., Ogura, A., Masuda, M., Kato, T., Maesawa, S., Katsuno, M., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac214 · Cited by 17
Significance of nicotine and nicotinic acetylcholine receptors in Parkinson’s disease
Xia, L., Li, Q., Pu, M., Dong, H., & Zhang, Q. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535310 · Cited by 20
Estimates of Intracellular Dopamine in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Sackner‐Bernstein, J. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212715 · Cited by 17
Unraveling the AKT/ERK cascade and its role in Parkinson disease
Keshri, P. K., & Singh, S. P. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03829-9 · Cited by 17
Xie, Y., Sun, W., Han, A., Zhou, X., Zhang, S., Shen, C., Xie, Y., Wang, C., & Xie, N. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1527013 · Cited by 17
Biology of endophilin and it’s role in disease
Yang, L.-Q., Huang, A., & Xu, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1297506 · Cited by 16
Zalon, A. J., Quiriconi, D. J., Pitcairn, C., & Mazzulli, J. R. (2024) · The Neuroscientist · doi:10.1177/10738584241232963 · Cited by 16
Zhou, S., Xiong, X., Hou, J., Duan, Q., Zheng, Y., Jiang, T., Huang, J., He, H., Xu, J., Chen, K., et al. (2025) · Advanced Science · doi:10.1002/advs.202408503 · Cited by 15
Zhao, J., Li, Y., Li, Y., Xu, S., Tao, T., Ye, H., Zhang, J., & Fan, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.637319 · Cited by 15
Duperrier, S., Bortolozzi, A. A., & Sgambato, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158586 · Cited by 16
Song, D., Yuan, L., Cui, N., Feng, C., Meng, L., Wang, X., Xiang, M., Liu, D., Wang, C., Zhang, Z., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15974 · Cited by 16
Neuroprotection of phytic acid in Parkinson’s and Alzheimer’s disease
Chen, Y., Yuan, W., Xu, Q., & Reddy, M. B. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105856 · Cited by 16
Actin-nucleation promoting factor N-WASP influences alpha-synuclein condensates and pathology
Jackson, J., Hoffmann, C., Scifo, E., Wang, H., Wischhof, L., Piazzesi, A., Mondal, M., Shields, H., Zhou, X., Mondin, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06686-7 · Cited by 14
The Osteocyte Transcriptome: Discovering Messages Buried Within Bone
Wee, N. K. Y., Sims, N. A., & Morello, R. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00708-5 · Cited by 15
Garza, N. M., Griffin, A. T., Zulkifli, M., Qiu, C., Kaplan, C. D., & Gohil, V. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100485 · Cited by 14
Xiao, Z., Yan, Z., Sun, X., Zhu, Z., Wang, B., Gao, M., Lu, F., Liu, J., Zong, Z., Zhang, H., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9173514 · Cited by 14
Novel approaches to counter protein aggregation pathology in Parkinson's disease
Stott, S., Wyse, R. K. H., & Brundin, P. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.007 · Cited by 16
Oligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo
Sarkar, S., Bardai, F. H., Olsen, A. L., Lohr, K. M., Zhang, Y., & Feany, M. Β. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00454-3 · Cited by 13
Liu, Z., Zhuang, W., Cai, M., Lv, E., Wang, Y., Wu, Z., Wang, H., & Fu, W. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03819-2 · Cited by 15
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach
Visanji, N. P., Ghani, M., Yu, E., Kakhki, E. G., Sato, C., Moreno, D., Naranian, T., Poon, Y.-Y., Abdollahi, M., Naghibzadeh, M., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212730 · Cited by 13
Dysregulation of Immune Mediators and Synaptic Plasticity in Central Nervous System Disorders
Imbriani, P., D’Ambra, C., Mori, R. D., Ionta, M., Renna, A., & Bonsi, P. (2026) · Cells · doi:10.3390/cells15020201 · Cited by 15
Genetic Analysis of HSP40/DNAJ Family Genes in Parkinson’s Disease: a Large Case-Control Study
Zhang, K., Pan, H., Zhao, Y., Wang, Y., Zeng, Q., Zhou, X. C., He, R., Zhou, X., Xiang, Y., Zhou, Z., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02920-5 · Cited by 13
α-Synuclein and biological membranes: the danger of loving too much
Mansueto, S., Fusco, G., & Simone, A. D. (2023) · Chemical Communications · doi:10.1039/d3cc01682j · Cited by 15
Geng, X., Zou, Y., Huang, T., Li, S., Pang, A., & Yu, H. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02186-z · Cited by 13
Role of mitochondrial quality control in neurodegenerative disease progression
Liu, T., Sun, W., Guo, S., Yuan, Z., Zhu, M., Lu, J., Chen, T., Qu, Y., Feng, C., & Yang, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1588645 · Cited by 16
Aleksandrova, Y. R., Chaprov, K., Podturkina, A. V., Ardashov, O. V., Yandulova, E. Y., Volcho, K. P., Salakhutdinov, N. F., & Неганова, М. Е. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065842 · Cited by 12
Sassone, J., Valtorta, F., & Ciammola, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00273 · Cited by 13
Manzoor, R., Rasool, A., Ahmed, M., Ullah, K., Duru, L. N., Ma, H., & Deng, Y. (2020) · Molecules · doi:10.3390/molecules25071715 · Cited by 15
Meng, J., Wang, F., Ji, L., Liang, Y., Wei, N., Song, L., & Zhu, A. (2021) · Epigenomics · doi:10.2217/epi-2021-0176 · Cited by 12
Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
Chen, Y., Wu, Z., Li, S., Chen, Q., Wang, L., Qi, X., Tian, C., & Yang, M. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s458026 · Cited by 12
The major histocompatibility complex participates in Parkinson’s disease
Gu, R., Pan, J., Awan, M. U. N., Sun, X., Fang, Y., Bai, L., & Bai, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107168 · Cited by 14
Diverse Functions of Parkin in Midbrain Dopaminergic Neurons
Song, P., & Krainc, D. (2024) · Movement Disorders · doi:10.1002/mds.29890 · Cited by 13
Self-citationGao, J.-M., Li, W.-B., Yang, Y., Wei, J., Gong, M., Pan, B.-B., Su, X.-C., Pan, Y., Guo, D., & Gong, Q. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123378 · Cited by 12
Kasap, M., & Dwyer, D. S. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02348-6 · Cited by 13
Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease
Tian, Y., He, M., Pan, L., Yuan, X., Xiong, M., Meng, L., Yao, Z., Yu, Z., Ye, K., & Zhang, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.760781 · Cited by 12
1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
Ortíz de Zárate, A., Pérez-Torralba, M., Bonet Isidro, I., López, C., Claramunt, R. M., Martínez-Casanova, D., Sánchez-Vera, I., Jiménez-González, J., & Lavandera, J. L. (2021) · Antioxidants · doi:10.3390/antiox10101584 · Cited by 11
Ali, I., Adil, M., Imran, M., Qureshi, S. A., Qureshi, S., Hasan, N., & Ahmad, F. J. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01799-8 · Cited by 11
Khalaf, M. M., El-Sayed, M. M., Kandeil, M. A., & Ahmed, S. A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110170 · Cited by 11
The role of SGK1 in neurologic diseases: A friend or foe?
Chen, X., Kang, H., & Xiao, Y. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.12.003 · Cited by 10
Ranjan, S., Choudhary, P., Shivalkar, S., Dwivedi, S., & Singh, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142981 · Cited by 10
Luo, F., Luo, S., Qian, W., Zhang, L., Chen, C., Xu, M., Wang, G., Wang, Z., Wang, J., & Wang, W. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102027 · Cited by 10
Li, Y., Wang, T., Meng, L., Lei, J., Liu, C., Liang, Y., Ren, L., Liu, Y., Liu, Y., Liu, S., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12860 · Cited by 10
Walker, C. K., Greathouse, K. M., Tuscher, J. J., Dammer, E. B., Weber, A. J., Liu, E., Curtis, K. A., Boros, B. D., Freeman, C. D., Seo, J. V., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2102-22.2023 · Cited by 12
FIG4-Related Parkinsonism and the Particularities of the I41T Mutation: A Review of the Literature
Boura, I., Giannopoulou, I. A., Pavlaki, V., Xiromerisiou, G., Mitsias, P. D., & Spanaki, C. (2024) · Genes · doi:10.3390/genes15101344 · Cited by 9
Boura, I., Popławska-Domaszewicz, K., Limbachiya, N., Trivedi, D., Batzu, L., & Chaudhuri, К. R. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2024.12.004 · Cited by 11
Xu, Q.-H., Wang, Y., Wang, C., Jiang, S., Zhang, B., & Tian, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-91344-x · Cited by 9
Wen, Y., Han, Z., Wang, B., Feng, C., Ding, X., Li, Y., Lv, Y., Wang, X., & Gao, L. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01575-9 · Cited by 9
Song, L., Sui, R., Wang, J., Miao, Q., He, Y., Yin, J.-J., An, J., Ding, Z., Han, Q.-X., Wang, Q., et al. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2100778 · Cited by 9
Behavioral screening defines three molecular Parkinsonism subgroups in DrosophilaPreprint
Kaempf, N., Valadas, J. S., Robberechts, P., Schoovaerts, N., Praschberger, R., Ortega, A., Kilic, A., Chabot, D., Pech, U., Kuenen, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.27.609924 · Cited by 9
Metadata
- Authors
- Nguyen, M., Wong, Y. C., Ysselstein, D., Severino, A., & Krainc, D.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Krainc, Dimitri
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 42
- Issue
- 2
- Pages
- 140-149
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC6452863
- OpenAlex
- W2903418495
- Cited by
- 323
- References
- 89
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 53 · 2023: 42 · 2022: 45 · 2021: 57 · 2020: 45 · 2019: 18
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (2T32AG020506-16, K99 NS109252, T32 NS041234, R01 NS076054, R37 NS096241)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- Parkinson's disease, synaptic vesicle endocytosis, mitochondrial dysfunction, oxidative stress, DNAJC6, auxilin, SYNJ1, SH3GL2, endophilin A1, LRRK2, Parkin, VPS35, midbrain dopaminergic neurons, selective neuronal vulnerability, risk genes
- MeSH terms
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Animals, Autophagy, Dopamine, Endocytosis, Humans, Lysosomes, Mitochondria, Parkinson Disease, Synaptic Vesicles, Oxidative Stress, Genetic Predisposition to Disease, alpha-Synuclein, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
